https://www.grunenthal.it/ 2025-02-06 daily 0.5 https://www.grunenthal.it/chi_siamo 2024-08-22 daily 0.5 https://www.grunenthal.it/scienza 2024-08-22 daily 0.5 https://www.grunenthal.it/lavoro_carriera 2025-02-24 daily 0.5 https://www.grunenthal.it/press-room 2025-05-07 daily 0.5 https://www.grunenthal.it/footer-links 2024-08-22 daily 0.5 https://www.grunenthal.it/searchresults 2024-08-22 daily 0.5 https://www.grunenthal.it/chi_siamo/la_nostra_azienda 2024-08-22 daily 0.5 https://www.grunenthal.it/chi_siamo/la_nostra_storia 2025-02-03 daily 0.5 https://www.grunenthal.it/chi_siamo/la_nostra_leadership 2025-06-13 daily 0.5 https://www.grunenthal.it/chi_siamo/farmacovigilanza 2024-08-22 daily 0.5 https://www.grunenthal.it/chi_siamo/la_nostra_responsabilita 2025-03-21 daily 0.5 https://www.grunenthal.it/chi_siamo/portfolio-prodotti 2025-02-11 daily 0.5 https://www.grunenthal.it/chi_siamo/compliance 2025-08-11 daily 0.5 https://www.grunenthal.it/chi_siamo/presenza_a_livello_mondiale 2025-01-22 daily 0.5 https://www.grunenthal.it/chi_siamo/iniziative-medici-farmacisti 2025-07-10 daily 0.5 https://www.grunenthal.it/chi_siamo/iniziative-risorse-pazienti 2025-07-10 daily 0.5 https://www.grunenthal.it/scienza/strategia-ricerca 2024-08-22 daily 0.5 https://www.grunenthal.it/scienza/collabora-con-noi 2024-08-22 daily 0.5 https://www.grunenthal.it/scienza/pipeline 2024-08-22 daily 0.5 https://www.grunenthal.it/scienza/aree-di-ricerca 2024-08-22 daily 0.5 https://www.grunenthal.it/scienza/studi-clinici 2024-08-22 daily 0.5 https://www.grunenthal.it/lavoro_carriera/nostra_cultura 2024-08-22 daily 0.5 https://www.grunenthal.it/lavoro_carriera/vieni_a_conoscere_le_nostre_persone 2025-02-04 daily 0.5 https://www.grunenthal.it/press-room/la-risposta-di-gruenenthal-all-emergenza-covid-19 2024-08-22 daily 0.5 https://www.grunenthal.it/press-room/comunicati_stampa 2025-04-02 daily 0.5 https://www.grunenthal.it/press-room/stories-archiv 2024-08-22 daily 0.5 https://www.grunenthal.it/press-room/corporate-publications 2025-05-12 daily 0.5 https://www.grunenthal.it/press-room/features 2024-08-22 daily 0.5 https://www.grunenthal.it/press-room/immagini 2025-06-03 daily 0.5 https://www.grunenthal.it/press-room/risorse_video 2024-08-22 daily 0.5 https://www.grunenthal.it/footer-links/altre-informative-privacy 2025-03-14 daily 0.5 https://www.grunenthal.it/footer-links/contact 2024-08-22 daily 0.5 https://www.grunenthal.it/footer-links/responsible-usage-statement-it 2024-08-22 daily 0.5 https://www.grunenthal.it/footer-links/condizioni 2025-01-16 daily 0.5 https://www.grunenthal.it/footer-links/errore-500 2024-08-22 daily 0.5 https://www.grunenthal.it/footer-links/imprint 2024-08-22 daily 0.5 https://www.grunenthal.it/footer-links/informativa_in_materia_di_privacy 2024-08-22 daily 0.5 https://www.grunenthal.it/footer-links/privacy-statement-hcp-it 2024-08-22 daily 0.5 https://www.grunenthal.it/footer-links/privacy-statement-facebook 2024-08-22 daily 0.5 https://www.grunenthal.it/footer-links/sitemap 2024-08-22 daily 0.5 https://www.grunenthal.it/footer-links/errore-404 2024-08-22 daily 0.5 https://www.grunenthal.it/chi_siamo/la_nostra_responsabilita/ambiente-salute-e-sicurezza 2025-08-20 daily 0.5 https://www.grunenthal.it/chi_siamo/la_nostra_responsabilita/responsabile-uso-di-opioids 2025-04-02 daily 0.5 https://www.grunenthal.it/chi_siamo/la_nostra_responsabilita/talidomide 2025-04-14 daily 0.5 https://www.grunenthal.it/chi_siamo/compliance/codice_di_transparenza_efpia 2025-06-24 daily 0.5 https://www.grunenthal.it/chi_siamo/presenza_a_livello_mondiale/filiali-in-asia 2024-08-22 daily 0.5 https://www.grunenthal.it/chi_siamo/presenza_a_livello_mondiale/filiali-in-italia-e-in-europa 2024-08-22 daily 0.5 https://www.grunenthal.it/chi_siamo/presenza_a_livello_mondiale/filiali-in-usa-e-america-latina 2024-08-22 daily 0.5 https://www.grunenthal.it/chi_siamo/presenza_a_livello_mondiale/siti_produttivi 2024-08-22 daily 0.5 https://www.grunenthal.it/chi_siamo/presenza_a_livello_mondiale/origgio 2024-08-22 daily 0.5 https://www.grunenthal.it/chi_siamo/iniziative-medici-farmacisti/gruenenthal-forward-academy 2024-08-22 daily 0.5 https://www.grunenthal.it/chi_siamo/iniziative-medici-farmacisti/rapporto-censis-grunenthal 2025-01-17 daily 0.5 https://www.grunenthal.it/chi_siamo/iniziative-medici-farmacisti/grunenthal-health 2024-08-22 daily 0.5 https://www.grunenthal.it/chi_siamo/iniziative-medici-farmacisti/science_of_relief 2024-11-18 daily 0.5 https://www.grunenthal.it/chi_siamo/iniziative-risorse-pazienti/dimensione-sollievo 2025-01-17 daily 0.5 https://www.grunenthal.it/chi_siamo/iniziative-risorse-pazienti/rapporto-censis-gruenenthal 2025-01-17 daily 0.5 https://www.grunenthal.it/chi_siamo/iniziative-risorse-pazienti/manifesto-sociale 2024-08-22 daily 0.5 https://www.grunenthal.it/scienza/strategia-ricerca/innovation-hub 2024-08-22 daily 0.5 https://www.grunenthal.it/lavoro_carriera/vieni_a_conoscere_le_nostre_persone/serena-doldi 2025-02-04 daily 0.5 https://www.grunenthal.it/lavoro_carriera/vieni_a_conoscere_le_nostre_persone/giuseppe-cilia 2024-08-22 daily 0.5 https://www.grunenthal.it/lavoro_carriera/vieni_a_conoscere_le_nostre_persone/cristina-gratiela-halunga 2024-08-22 daily 0.5 https://www.grunenthal.it/press-room/comunicati_stampa/2025 2025-04-02 daily 0.5 https://www.grunenthal.it/press-room/comunicati_stampa/2024 2024-08-22 daily 0.5 https://www.grunenthal.it/press-room/comunicati_stampa/2023 2024-08-22 daily 0.5 https://www.grunenthal.it/press-room/comunicati_stampa/2022 2024-08-22 daily 0.5 https://www.grunenthal.it/press-room/comunicati_stampa/2021 2024-08-22 daily 0.5 https://www.grunenthal.it/press-room/comunicati_stampa/2020 2024-08-22 daily 0.5 https://www.grunenthal.it/press-room/comunicati_stampa/2019 2024-08-22 daily 0.5 https://www.grunenthal.it/press-room/stories-archiv/miglior-punteggio-di-sempre-per-la-gestione-del-rischio 2025-05-08 daily 0.5 https://www.grunenthal.it/press-room/stories-archiv/progetto-formativo-la-gruenenthal-forward-academy 2025-02-04 daily 0.5 https://www.grunenthal.it/press-room/stories-archiv/100-ragioni-serena-doldi 2025-02-04 daily 0.5 https://www.grunenthal.it/press-room/stories-archiv/premio-assochange-2024 2025-02-04 daily 0.5 https://www.grunenthal.it/press-room/stories-archiv/beth-vivere-con-emicrania 2025-02-04 daily 0.5 https://www.grunenthal.it/press-room/stories-archiv/grunenthal-supporta-programma-wet-lab 2025-02-04 daily 0.5 https://www.grunenthal.it/press-room/stories-archiv/nasce-la-gruenenthal-forward-academy 2025-02-04 daily 0.5 https://www.grunenthal.it/press-room/stories-archiv/company-report-di-gruenenthal 2025-02-04 daily 0.5 https://www.grunenthal.it/press-room/stories-archiv/rapporto-censis-gruenenthal-dolore-cronico-il-grande-taciuto-della-societa-italiana 2025-02-04 daily 0.5 https://www.grunenthal.it/press-room/stories-archiv/giornata-mondiale-del-cancro-paziente-esperienza-storia-carina 2025-02-04 daily 0.5 https://www.grunenthal.it/press-room/stories-archiv/rapporto-censis-gruenenthal 2025-02-04 daily 0.5 https://www.grunenthal.it/press-room/stories-archiv/sito-produttivo-gruenenthal-ad-origgio-supera-l-audit-della-fda 2025-02-04 daily 0.5 https://www.grunenthal.it/press-room/stories-archiv/la-fotografia-del-dolore-cronico-in-italia 2025-02-04 daily 0.5 https://www.grunenthal.it/press-room/stories-archiv/iniziative-emergenza-gruenenthal 2025-02-04 daily 0.5 https://www.grunenthal.it/press-room/stories-archiv/rtx-breakthrough-therapy-designation 2025-02-04 daily 0.5 https://www.grunenthal.it/press-room/stories-archiv/medquestio 2025-02-04 daily 0.5 https://www.grunenthal.it/press-room/stories-archiv/certificazione-genere 2024-08-22 daily 0.5 https://www.grunenthal.it/press-room/stories-archiv/dimensione-sollievo-podcast 2025-02-04 daily 0.5 https://www.grunenthal.it/press-room/stories-archiv/visita-istituzionale-allo-stabilimento-di-origgio 2024-08-22 daily 0.5 https://www.grunenthal.it/press-room/stories-archiv/sciencemademe-mariastupar 2024-08-22 daily 0.5 https://www.grunenthal.it/press-room/stories-archiv/aperte-le-candidature-all-egg-2023 2025-02-04 daily 0.5 https://www.grunenthal.it/press-room/stories-archiv/impegno-grunenthal-per-futuro-sostenibile-e-responsabile 2025-02-04 daily 0.5 https://www.grunenthal.it/press-room/stories-archiv/grunenthal-progetti-green-riforestazione 2025-02-04 daily 0.5 https://www.grunenthal.it/press-room/stories-archiv/gruenenthal-sostiene-i-soccorso-in-ucraina 2024-08-22 daily 0.5 https://www.grunenthal.it/press-room/stories-archiv/manifesto-sociale-contro-la-sofferenza 2025-02-04 daily 0.5 https://www.grunenthal.it/press-room/stories-archiv/progetto-relief 2024-08-22 daily 0.5 https://www.grunenthal.it/press-room/stories-archiv/trpv1-applicazioni-scienza-da-nobel 2024-08-22 daily 0.5 https://www.grunenthal.it/press-room/stories-archiv/gestire-il-dolore-con-innovazione 2024-08-22 daily 0.5 https://www.grunenthal.it/press-room/stories-archiv/alluvione-grunenthal-dona-400000-euro-come-aiuto-emergenza 2024-08-22 daily 0.5 https://www.grunenthal.it/press-room/stories-archiv/gruenenthal-sos-farmacie 2024-08-22 daily 0.5 https://www.grunenthal.it/press-room/stories-archiv/campagna-in-dolore 2024-08-22 daily 0.5 https://www.grunenthal.it/press-room/stories-archiv/grunenthal-acquisisce-mestex-ag 2024-08-22 daily 0.5 https://www.grunenthal.it/press-room/stories-archiv/gruenenthal-certificazione-gptwa-grunenthal-in-italia 2024-08-22 daily 0.5 https://www.grunenthal.it/press-room/stories-archiv/entra-nello-sviluppo-clinico-l-agonista-nop-periferico-per-il-dolore-neuropatico-periferico-cronico 2024-08-22 daily 0.5 https://www.grunenthal.it/press-room/stories-archiv/science-of-relief-2020 2024-08-22 daily 0.5 https://www.grunenthal.it/press-room/stories-archiv/in-dolore-per-la-gestione-del-dolore-cronico 2024-08-22 daily 0.5 https://www.grunenthal.it/press-room/stories-archiv/grunenthal-sostiene-h-open-week-2020-fondazione-onda-ospedali-bollini-rosa 2024-08-22 daily 0.5 https://www.grunenthal.it/press-room/stories-archiv/change-pain-website-grunenthal-dolore-cronico-pazienti-materiale-educazionale 2024-08-22 daily 0.5 https://www.grunenthal.it/press-room/stories-archiv/l-annual-report-2019-2020-approfondimenti-sull-anno-da-record-per-il-gruppo-gruenenthal 2024-08-22 daily 0.5 https://www.grunenthal.it/press-room/stories-archiv/10-anni-della-legge-38 2024-08-22 daily 0.5 https://www.grunenthal.it/press-room/stories-archiv/ispezione-fda-riuscita-per-il-sito-di-origgio 2024-08-22 daily 0.5 https://www.grunenthal.it/press-room/stories-archiv/egg-giovani-ricercatori-europei-possono-presentare-progetto-di-ricerca-area-del-dolore-cronico 2024-08-22 daily 0.5 https://www.grunenthal.it/press-room/stories-archiv/esplorare-potenziali-partnerships-alla-jp-morgan-healthcare-conference 2024-08-22 daily 0.5 https://www.grunenthal.it/press-room/stories-archiv/grunenthal-mesoblast-partnership-per-sviluppo-e-commercializzazione-di-terapia-cellulare-innovativa 2024-08-22 daily 0.5 https://www.grunenthal.it/press-room/stories-archiv/soddisfare-aziende-farmaceutiche-clienti-grazie-a-eccellenza-sito-produttivo-grunenthal 2024-08-22 daily 0.5 https://www.grunenthal.it/press-room/comunicati_stampa/2025/prof-dr-uli-broedl-appointed-as-new-gruenenthal-cso 2025-04-02 daily 0.5 https://www.grunenthal.it/press-room/comunicati_stampa/2024/rapporto-censis-gruenenthal-i-costi-del-dolore-cronico 2025-01-09 daily 0.5 https://www.grunenthal.it/press-room/comunicati_stampa/2024/grunenthal-acquires-us-company-valinor-pharma 2024-08-22 daily 0.5 https://www.grunenthal.it/press-room/comunicati_stampa/2024/donne-e-dolore-cronico-rapporto-censis-grunenthal 2024-08-22 daily 0.5 https://www.grunenthal.it/press-room/comunicati_stampa/2024/presidenti-osnato-e-baffi-in-visita-presso-lo-stabilimento-grunenthal-a-origgio 2024-08-22 daily 0.5 https://www.grunenthal.it/press-room/comunicati_stampa/2024/2023-full-year-result-gruenenthal 2024-08-22 daily 0.5 https://www.grunenthal.it/press-room/comunicati_stampa/2024/dolore-cronico-il-grande-taciuto-della-societa-italiana-rapporto-censis-grunenthal 2024-08-22 daily 0.5 https://www.grunenthal.it/press-room/comunicati_stampa/2023/censis-grunenthal-dolore-cronico-rapporto-vivere-senza-dolore 2024-08-22 daily 0.5 https://www.grunenthal.it/press-room/comunicati_stampa/2023/dolore-cronico-online-medicina-narrativa 2024-08-22 daily 0.5 https://www.grunenthal.it/press-room/comunicati_stampa/2023/origgio-supera-audit-fda 2024-08-22 daily 0.5 https://www.grunenthal.it/press-room/comunicati_stampa/2023/dolore-cronico-web-survey-di-dimensione-sollievo 2024-08-22 daily 0.5 https://www.grunenthal.it/press-room/comunicati_stampa/2023/closing-of-joint-venture-with-kyowa-kirin 2024-08-22 daily 0.5 https://www.grunenthal.it/press-room/comunicati_stampa/2023/progetti-vincitori-efic-gruenenthal-grant-2023 2024-08-22 daily 0.5 https://www.grunenthal.it/press-room/comunicati_stampa/2023/pr-fda-breakthrough-therapy-designation-resiniferatoxin-it 2024-08-22 daily 0.5 https://www.grunenthal.it/press-room/comunicati_stampa/2023/dimensione-sollievo-spotify-podcast 2024-08-22 daily 0.5 https://www.grunenthal.it/press-room/comunicati_stampa/2023/grunenthal-riceve-certificazione-per-parita-di-genere 2024-08-22 daily 0.5 https://www.grunenthal.it/press-room/comunicati_stampa/2023/scuola-del-mal-di-schiena 2024-08-22 daily 0.5 https://www.grunenthal.it/press-room/comunicati_stampa/2023/l-assessore-regionale-guidesi 2024-08-22 daily 0.5 https://www.grunenthal.it/press-room/comunicati_stampa/2023/michela-barbarossa-head-of-legal-compliance-grunenthal-italia 2024-08-22 daily 0.5 https://www.grunenthal.it/press-room/comunicati_stampa/2023/laura-premoli-general-manager-gruenenthal-italia 2024-08-22 daily 0.5 https://www.grunenthal.it/press-room/comunicati_stampa/2022/aldo-sterpone-nuovo-head-of-latam-grunenthal 2024-08-22 daily 0.5 https://www.grunenthal.it/press-room/comunicati_stampa/2022/grunenthal-kyowa-kirin-international-joint-venture-collaboration-medicines-portfolio 2024-08-22 daily 0.5 https://www.grunenthal.it/press-room/comunicati_stampa/2022/sabrina-baldanzi-entra-nel-management-team-di-grunenthal-italia 2024-08-22 daily 0.5 https://www.grunenthal.it/press-room/comunicati_stampa/2022/programma-globale-clinico-fase-iii-per-la-resiniferatossina-rtx 2024-08-22 daily 0.5 https://www.grunenthal.it/press-room/comunicati_stampa/2022/grunenthal-acquisisce-da-bayer-ag-il-gold-standard-nebido 2024-08-22 daily 0.5 https://www.grunenthal.it/press-room/comunicati_stampa/2022/gabriel-baertschi-ceo-di-gruenenthal-visita-lo-stabilimento-produttivo-di-origgio 2024-08-22 daily 0.5 https://www.grunenthal.it/press-room/comunicati_stampa/2022/gruenenthal-2021-full-year-results 2024-08-22 daily 0.5 https://www.grunenthal.it/press-room/comunicati_stampa/2022/grunenthal-e-novaquest-siglano-accordo-per-avanzare-fase-iii-resiniferatoxin-rtx 2024-08-22 daily 0.5 https://www.grunenthal.it/press-room/comunicati_stampa/2022/nomina-market-access-government-affairs-gruenenthal-italia 2024-08-22 daily 0.5 https://www.grunenthal.it/press-room/comunicati_stampa/2021/manifesto-sociale-contro-dolore-cronico 2024-08-22 daily 0.5 https://www.grunenthal.it/press-room/comunicati_stampa/2021/arruolati-i-primi-partecipanti-di-uno-studio-clinico-con-agonista-del-recettore-peptidico-nop 2024-08-22 daily 0.5 https://www.grunenthal.it/press-room/comunicati_stampa/2021/grunenthal-acquisisce-mestex-ag 2024-08-22 daily 0.5 https://www.grunenthal.it/press-room/comunicati_stampa/2021/grunenthal-riconosciuta-per-la-sua-solida-gestione-dei-rischi-legati-all-esg 2024-08-22 daily 0.5 https://www.grunenthal.it/press-room/comunicati_stampa/2021/certificacione-great-place-to-work-grunenthal-italia 2024-08-22 daily 0.5 https://www.grunenthal.it/press-room/comunicati_stampa/2021/gruenenthal-conclude-l-accordo-con-astrazeneca-per-i-diritti-europei-di-crestor-rosuvastatina 2024-08-22 daily 0.5 https://www.grunenthal.it/press-room/comunicati_stampa/2020/grunenthal-italia-al-via-oggi-science-of-relief-2020 2024-08-22 daily 0.5 https://www.grunenthal.it/press-room/comunicati_stampa/2020/gruenenthal-trasmette-la-notifica-di-revoca-di-zurampic-e-duzallo-alla-ce-e-all-ema 2024-08-22 daily 0.5 https://www.grunenthal.it/press-room/comunicati_stampa/2020/a-dieci-anni-dall-attuazione-della-legge-38-cosa-e-stato-fatto-e-cosa-c-e-ancora-da-fare 2024-08-22 daily 0.5 https://www.grunenthal.it/press-room/comunicati_stampa/2020/a-grunenthal-l-autorizzazione-all-immissione-in-commercio-per-esomeprazolo 2024-08-22 daily 0.5 https://www.grunenthal.it/press-room/comunicati_stampa/2020/paola-ianna-nomiata-direttore-market-access-government-affairs 2024-08-22 daily 0.5 https://www.grunenthal.it/press-room/comunicati_stampa/2020/grunenthal-grant-nuove-opportunita-di-ricerca-per-i-giovani-europei 2024-08-22 daily 0.5 https://www.grunenthal.it/press-room/comunicati_stampa/2020/grunenthal-inaugura-nuovo-innovation-hub-a-boston 2024-08-22 daily 0.5 https://www.grunenthal.it/press-room/comunicati_stampa/2020/opportunita-di-lavoro-presso-farmaceutici-lo-stabilmento-produttivo-di-grunenthal-italia 2024-08-22 daily 0.5 https://www.grunenthal.it/press-room/comunicati_stampa/2019/grunenthal-italia-nomina-chiara-lattuada-responsabile-della-comunicazione 2024-08-22 daily 0.5 https://www.grunenthal.it/press-room/comunicati_stampa/2019/grunenthal-italia-nomina-federica-diverio-head-of-finance-and-controlling 2024-08-22 daily 0.5 https://www.grunenthal.it/press-room/comunicati_stampa/2019/grunenthal-italia-nomina-luigi-uccella-human-ressources-director 2024-08-22 daily 0.5 https://www.grunenthal.it/press-room/comunicati_stampa/2019/grunenthal-italia-nomina-laura-premoli-head-of-marketing 2024-08-22 daily 0.5 https://www.grunenthal.it/press-room/comunicati_stampa/2019/dolore-in-italia-la-sua-gestione-non-ancora-adeguata 2024-08-22 daily 0.5 https://www.grunenthal.it/press-room/comunicati_stampa/2019/salute-della-donna-gruenenthal-italia-al-fianco-di-onda-per-la-open-week 2024-08-22 daily 0.5